Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Rowan, Brian G ^a   Gimble, Jeffrey M ^b   Sheng, Mei ^a   Anbalagan, Muralidharan ^a   Jones, Ryan K ^a   Frazier, Trivia P ^a   Asher, Majdouline ^a   Lacayo, Eduardo A ^a   Friedlander, Paul L ^a   Kutner, Robert ^c   Chiu, Ernest S ^d  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 8; VASCULOTROPIN; VIMENTIN;

ADIPOSE TISSUE; ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CHROMOSOME 17; CONTROLLED STUDY; DNA CONTENT; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN METASTASIS; STROMA CELL; TUMOR GROWTH; TUMOR VOLUME;

ADIPOSE TISSUE; ANIMALS; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 9; MICE; STEM CELLS; STROMAL CELLS; TRIPLE NEGATIVE BREAST NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896509779     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089595     Document Type: Article

References (61)

1. Anbalagan M, Ali A, Jones RK, Marsden CG, Sheng M, et al. (2012) Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts. Mol Cancer Ther. 1535-7163.MCT-12-0146 [pii];10.1158/1535-7163.MCT- 12-0146 [doi].
2. Curry JM, Fisher KW, Heffelfinger RN, Rosen MR, Keane WM, et al. (2008) Superficial musculoaponeurotic system elevation and fat graft reconstruction after superficial parotidectomy. Laryngoscope 118: 210-215. 10.1097/MLG. 0b013e3181581f94 [doi]. (Pubitemid 351640188)
3. Coleman SR (1997) Facial recontouring with lipostructure. Clin Plast Surg 24: 347-367.
4. Cook T, Nakra T, Shorr N, Douglas RS (2004) Facial recontouring with autogenous fat. Facial Plast Surg 20: 145-147. 10.1055/s-2004-861755 [doi]. (Pubitemid 40075171)
5. Fournier PF (1990) Facial recontouring with fat grafting. Dermatol Clin 8: 523-537. (Pubitemid 20327110)
6. Kaufman MR, Miller TA, Huang C, Roostaeian J, Wasson KL, et al. (2007) Autologous fat transfer for facial recontouring: is there science behind the art? Plast Reconstr Surg 119: 2287-2296. 10.1097/01.prs.0000260712.44089.e7 [doi];00006534-200706000-00044 [pii]. (Pubitemid 46847129)
7. Hu S, Zhang H, Feng Y, Yang Y, Han X, et al. (2007) Introduction of an easy technique for purification and injection of autogenous free fat parcels in correcting of facial contour deformities. Ann Plast Surg 58: 602-607. 10.1097/01.sap.0000248110.59452.49 [doi];00000637-200706000-00002 [pii]. (Pubitemid 46816794)
8. Xie Y, Li Q, Zheng D, Lei H, Pu LL (2007) Correction of hemifacial atrophy with autologous fat transplantation. Ann Plast Surg 59: 645-653. 10.1097/SAP.0b013e318038fcb7 [doi];00000637-200712000-00010 [pii]. (Pubitemid 350211481)
9. Yoshimura K, Sato K, Aoi N, Kurita M, Inoue K, et al. (2008) Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatol Surg 34: 1178-1185. DSU34256 [pii];10.1111/j.1524-4725.2008.34256.x [doi].
10. Guijarro-Martinez R, Alba LM, Mateo MM, Torres MP, Pascual et al. (2010) Autologous fat transfer to the cranio-maxillofacial region: updates and controversies. J Craniomaxillofac Surg.
11. Hanson SE, Gutowski KA, Hematti P (2010) Clinical applications of mesenchymal stem cells in soft tissue augmentation. Aesthet Surg J 30: 838-842. 30/6/838 [pii];10.1177/1090820X10386364 [doi].
12. Sterodimas A, de FJ, Nicaretta B, Pitanguy I (2010) Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg 63: 1886-1892. S1748-6815(09)00753-0 [pii];10.1016/j.bjps.2009.10.028 [doi].
13. Choi JH, Gimble JM, Lee K, Marra KG, Rubin JP, et al. (2010) Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev 16: 413-426. 10.1089/ten.TEB.2009.0544 [doi].
14. Moseley TA, Zhu M, Hedrick MH (2006) Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 118: 121S-128S. 10.1097/01.prs.0000234609.74811.2e [doi];00006534-200609011-00016 [pii]. (Pubitemid 44319097)
15. Dubois SG, Floyd EZ, Zvonic S, Kilroy G, Wu X, et al. (2008) Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Methods Mol Biol 449: 69-79. 10.1007/978-1-60327-169-1-5 [doi].
16. Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative medicine. Circ Res 100: 1249-1260. 100/9/1249 [pii];10.1161/01.RES. 0000265074.83288.09 [doi]. (Pubitemid 46742916)
17. Delay E, Garson S, Tousson G, Sinna R (2009) Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 29: 360-376. S1090-820X(09)00319-7 [pii];10.1016/j.asj.2009.08. 010 [doi].
18. Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K (2008) Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 32: 48-55. 10.1007/s00266-007-9019-4 [doi].
19. Yoshimura K, Asano Y, Aoi N, Kurita M, Oshima Y, et al. (2010) Progenitorenriched adipose tissue transplantation as rescue for breast implant complications. Breast J 16: 169-175. TBJ873 [pii];10.1111/j.1524-4741.2009. 00873.x [doi].
20. Rigotti G, Marchi A, Stringhini P, Baroni G, Galie M, et al. (2010) Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesthetic Plast Surg 34: 475-480. 10.1007/s00266-010-9481-2 [doi].
21. Illouz YG, Sterodimas A (2009) Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg 33: 706-715. 10.1007/s00266-009-9377-1 [doi].
22. Zheng DN, Li QF, Lei H, Zheng SW, Xie YZ, et al. (2008) Autologous fat grafting to the breast for cosmetic enhancement: experience in 66 patients with long-term follow up. J Plast Reconstr Aesthet Surg 61: 792-798. S1748-6815(08)00053-3 [pii];10.1016/j.bjps.2007.08.036 [doi]. (Pubitemid 351970477)
23. Mizuno H, Hyakusoku H (2010) Fat grafting to the breast and adipose-derived stem cells: recent scientific consensus and controversy. Aesthet Surg J 30: 381-387. 30/3/381 [pii];10.1177/1090820X10373063 [doi].
24. Yoshimura K, Suga H, Eto H (2009) Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med 4: 265-273. 10.2217/17460751.4.2.265 [doi].
25. Perez-Cano R, Vranckx JJ, Lasso JM, Calabrese C, Merck B, et al. (2012) Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol 38: 382-389. S0748-7983(12)00231-4 [pii];10.1016/j.ejso.2012.02.178 [doi].
26. Bertolini F, Lohsiriwat V, Petit JY, Kolonin MG (2012) Adipose tissue cells, lipotransfer and cancer: A challenge for scientists, oncologists and surgeons. Biochim Biophys Acta 1826: 209-214. S0304-419X(12)00030-3 [pii];10.1016/j.bbcan.2012.04.004 [doi].
27. Lohsiriwat V, Curigliano G, Rietjens M, Goldhirsch A, Petit JY (2011) Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence? Breast 20: 351-357. S0960-9776(11)00005-1 [pii];10.1016/j.breast.2011.01.003 [doi].
28. Pearl RA, Leedham SJ, Pacifico MD (2012) The safety of autologous fat transfer in breast cancer: lessons from stem cell biology. J Plast Reconstr Aesthet Surg 65: 283-288. S1748-6815(11)00394-9 [pii];10.1016/j.bjps.2011.07.017 [doi].
29. Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, et al. (2011) Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 17: 93-106. 10.1089/ten.TEA.2010.0248 [doi].
30. Donnenberg VS, Zimmerlin L, Rubin JP, Donnenberg AD (2010) Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev 16: 567-575. 10.1089/ten.TEB.2010.0352 [doi].
31. Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, et al. (2009) Tissueresident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30: 589-597. bgp036 [pii];10.1093/carcin/bgp036 [doi].
32. Pinilla S, Alt E, Abdul Khalek FJ, Jotzu C, Muehlberg F, et al. (2009) Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 284: 80-85. S0304-3835(09)00271-7 [pii];10.1016/j.canlet.2009.04.013 [doi].
33. Welte G, Alt E, Devarajan E, Krishnappa S, Jotzu C, Song YH (2011) Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion. Mol Carcinog. 10.1002/mc.20854 [doi].
34. Devarajan E, Song YH, Krishnappa S, Alt E (2012) Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissueresident stem cells. Int J Cancer 131: 1023-1031. 10.1002/ijc.26493 [doi].
35. Xu Q, Wang L, Li H, Han Q, Li J, et al. (2012) Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelialmesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-beta. Int J Oncol 41: 959-968. 10.3892/ijo.2012.1541 [doi].
36. Rhodes LV, Muir SE, Elliott S, Guillot LM, Antoon JW, et al. (2010) Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Res Treat 121: 293-300. 10.1007/s10549-009-0458-2 [doi].
37. Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, et al. (2012) Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci U S A 109: 9786-9791. 1121160109 [pii];10.1073/pnas.1121160109 [doi].
38. Chandler EM, Berglund CM, Lee JS, Polacheck WJ, Gleghorn JP, et al. (2011) Stiffness of photocrosslinked RGD-alginate gels regulates adipose progenitor cell behavior. Biotechnol Bioeng 108: 1683-1692. 10.1002/bit.23079 [doi].
39. Chandler EM, Saunders MP, Yoon CJ, Gourdon D, Fischbach C (2011) Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors. Phys Biol 8: 015008. S1478-3975(11)65530-6 [pii];10.1088/1478-3975/8/1/ 015008 [doi].
40. Sun B, Roh KH, Park JR, Lee SR, Park SB, et al. (2009) Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy 11: 289-98, 1. 909786028 [pii];10.1080/14653240902807026 [doi].
41. Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, et al. (2010) Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 124: 317-326. 10.1007/s10549-010-0734-1 [doi].
42. Albarenque SM, Zwacka RM, Mohr A (2011) Both human and mouse mesenchymal stem cells promote breast cancer metastasis. Stem Cell Res 7: 163-171. S1873-5061(11)00060-2 [pii];10.1016/j.scr.2011.05.002 [doi].
43. Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Axel AE et al. (2007) Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB J 21: 3763-3770. fj.07-8832com [pii];10.1096/fj.07-8832com [doi]. (Pubitemid 350075164)
44. Sasser AK, Mundy BL, Smith KM, Studebaker AW, Axel AE et al. (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254: 255-264. S0304-3835(07)00116-4 [pii];10.1016/j.canlet.2007.03.012 [doi]. (Pubitemid 47161104)
45. Shin SY, Nam JS, Lim Y, Lee YH (2010) TNFalpha-exposed bone marrowderived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. J Biol Chem 285: 30731-30740. M110.128124 [pii];10.1074/jbc.M110.128124 [doi].
46. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-5U4.
47. Finn RS, Dering J, Ginther C, Wilson CA, Glaspy P et al. (2007) Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro. Breast Cancer Research and Treatment 105: 319-326. (Pubitemid 47596452)
48. Yu G, Floyd ZE, Wu X, Hebert T, Halvorsen YD et al. (2011) Adipogenic differentiation of adipose-derived stem cells. Methods Mol Biol 702: 193-200. 10.1007/978-1-61737-960-4-14 [doi].
49. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C (2008) Adipose-derived stem cells: Isolation, expansion and differentiation. Methods 45: 115-120. (Pubitemid 351885360)
50. Kutner RH, Zhang XY, Reiser J (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4: 495-505. nprot.2009.22 [pii];10.1038/nprot.2009.22 [doi].
51. Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan B, et al. (2011) KX- 01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor alpha positive breast cancer. Breast Cancer Res Treat. 10.1007/s10549-011-1513-3 [doi].
52. Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA, et al. (2008) Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast Cancer Res Treat. 10.1007/s10549-008-0216-x [doi].
53. Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R et al. (2012) "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies". BMC Cancer 12:10. 1471-2407-12-10 [pii];10.1186/1471-2407-12-10 [doi].
54. Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I et al. (2002) Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. British Journal of Cancer 87: 1328-1335. (Pubitemid 36009141)
55. Fromigue O, Hamidouche Z, Vaudin P, Lecanda F, Patino A et al. (2011) CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis. J Bone Miner Res 26: 1533-1542. 10.1002/jbmr.343 [doi].
56. Anbalagan M, Moroz K, Ali A, Carrier L, Glodowski S et al. (2012) Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancer. PLoS One 7: e33017. 10.1371/journal.pone.0033017 [doi];- PONE-D-11-21438 [pii].
57. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW et al. (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-206. (Pubitemid 23046895)
58. Strong AL, Strong TA, Rhodes LV, Semon JA, Zhang X et al. (2013) Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Res 15: R102. bcr3569 [pii];10.1186/bcr3569 [doi].
59. Jotzu C, Alt E, Welte G, Li J, Hennessy BT, Devarajan E et al. (2011) Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cell Oncol (Dordr) 34: 55-67. 10.1007/s13402-011-0012-1 [doi].
60. Walter M, Liang S, Ghosh S, Hornsby PJ, Li R (2009) Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745-2755. onc2009130 [pii];10.1038/onc.2009.130 [doi].
61. Martin-Padura I, Gregato G, Marighetti P, Mancuso P, Calleri A et al. (2012) The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression. Cancer Res 72: 325-334. 0008-5472.CAN-11-1739 [pii];10.1158/0008-5472.CAN-11-1739 [doi].